These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 27138984)

  • 1. Intraneuronal aggregation of the β-CTF fragment of APP (C99) induces Aβ-independent lysosomal-autophagic pathology.
    Lauritzen I; Pardossi-Piquard R; Bourgeois A; Pagnotta S; Biferi MG; Barkats M; Lacor P; Klein W; Bauer C; Checler F
    Acta Neuropathol; 2016 Aug; 132(2):257-276. PubMed ID: 27138984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Transcription Factor EB Reduces the Intraneuronal Accumulation of the Beta-Secretase-Derived APP Fragment C99 in Cellular and Mouse Alzheimer’s Disease Models.
    Bécot A; Pardossi-Piquard R; Bourgeois A; Duplan E; Xiao Q; Diwan A; Lee JM; Lauritzen I; Checler F
    Cells; 2020 May; 9(5):. PubMed ID: 32408680
    [No Abstract]   [Full Text] [Related]  

  • 3. Presenilin/γ-Secretase Activity Is Located in Acidic Compartments of Live Neurons.
    Maesako M; Houser MCQ; Turchyna Y; Wolfe MS; Berezovska O
    J Neurosci; 2022 Jan; 42(1):145-154. PubMed ID: 34810230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The β-secretase-derived C-terminal fragment of βAPP, C99, but not Aβ, is a key contributor to early intraneuronal lesions in triple-transgenic mouse hippocampus.
    Lauritzen I; Pardossi-Piquard R; Bauer C; Brigham E; Abraham JD; Ranaldi S; Fraser P; St-George-Hyslop P; Le Thuc O; Espin V; Chami L; Dunys J; Checler F
    J Neurosci; 2012 Nov; 32(46):16243-1655a. PubMed ID: 23152608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial dysfunction and accumulation of the β-secretase-cleaved C-terminal fragment of APP in Alzheimer's disease transgenic mice.
    Devi L; Ohno M
    Neurobiol Dis; 2012 Jan; 45(1):417-24. PubMed ID: 21933711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accumulation of amyloid precursor protein C-terminal fragments triggers mitochondrial structure, function, and mitophagy defects in Alzheimer's disease models and human brains.
    Vaillant-Beuchot L; Mary A; Pardossi-Piquard R; Bourgeois A; Lauritzen I; Eysert F; Kinoshita PF; Cazareth J; Badot C; Fragaki K; Bussiere R; Martin C; Mary R; Bauer C; Pagnotta S; Paquis-Flucklinger V; Buée-Scherrer V; Buée L; Lacas-Gervais S; Checler F; Chami M
    Acta Neuropathol; 2021 Jan; 141(1):39-65. PubMed ID: 33079262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zinc and Copper Differentially Modulate Amyloid Precursor Protein Processing by γ-Secretase and Amyloid-β Peptide Production.
    Gerber H; Wu F; Dimitrov M; Garcia Osuna GM; Fraering PC
    J Biol Chem; 2017 Mar; 292(9):3751-3767. PubMed ID: 28096459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ErbB2 regulates autophagic flux to modulate the proteostasis of APP-CTFs in Alzheimer's disease.
    Wang BJ; Her GM; Hu MK; Chen YW; Tung YT; Wu PY; Hsu WM; Lee H; Jin LW; Hwang SL; Chen RP; Huang CJ; Liao YF
    Proc Natl Acad Sci U S A; 2017 Apr; 114(15):E3129-E3138. PubMed ID: 28351972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Turnover of C99 is controlled by a crosstalk between ERAD and ubiquitin-independent lysosomal degradation in human neuroglioma cells.
    Bustamante HA; Rivera-Dictter A; Cavieres VA; Muñoz VC; González A; Lin Y; Mardones GA; Burgos PV
    PLoS One; 2013; 8(12):e83096. PubMed ID: 24376644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of autophagy dysfunction in the TgCRND8 mouse model of Alzheimer's disease ameliorates amyloid pathologies and memory deficits.
    Yang DS; Stavrides P; Mohan PS; Kaushik S; Kumar A; Ohno M; Schmidt SD; Wesson D; Bandyopadhyay U; Jiang Y; Pawlik M; Peterhoff CM; Yang AJ; Wilson DA; St George-Hyslop P; Westaway D; Mathews PM; Levy E; Cuervo AM; Nixon RA
    Brain; 2011 Jan; 134(Pt 1):258-77. PubMed ID: 21186265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does Intraneuronal Accumulation of Carboxyl-terminal Fragments of the Amyloid Precursor Protein Trigger Early Neurotoxicity in Alzheimer's Disease?
    Lauritzen I; Pardossi-Piquard R; Bourgeois A; Bécot A; Checler F
    Curr Alzheimer Res; 2019; 16(5):453-457. PubMed ID: 30907322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BACE1 Cleavage Site Selection Critical for Amyloidogenesis and Alzheimer's Pathogenesis.
    Zhang S; Wang Z; Cai F; Zhang M; Wu Y; Zhang J; Song W
    J Neurosci; 2017 Jul; 37(29):6915-6925. PubMed ID: 28626014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific antibody binding to the APP672-699 region shifts APP processing from α- to β-cleavage.
    Li S; Deng J; Hou H; Tian J; Giunta B; Wang Y; Sawmiller D; Smith A; Sanberg PR; Obregon D; Mori T; Tan J
    Cell Death Dis; 2014 Aug; 5(8):e1374. PubMed ID: 25118934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is γ-secretase a beneficial inactivating enzyme of the toxic APP C-terminal fragment C99?
    Checler F; Afram E; Pardossi-Piquard R; Lauritzen I
    J Biol Chem; 2021; 296():100489. PubMed ID: 33662398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased Alzheimer's disease-like pathology in the APP/ PS1ΔE9 mouse model lacking Nrf2 through modulation of autophagy.
    Joshi G; Gan KA; Johnson DA; Johnson JA
    Neurobiol Aging; 2015 Feb; 36(2):664-79. PubMed ID: 25316599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MT5-MMP controls APP and β-CTF/C99 metabolism through proteolytic-dependent and -independent mechanisms relevant for Alzheimer's disease.
    García-González L; Paumier JM; Louis L; Pilat D; Bernard A; Stephan D; Jullien N; Checler F; Nivet E; Khrestchatisky M; Baranger K; Rivera S
    FASEB J; 2021 Jul; 35(7):e21727. PubMed ID: 34117802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sphingolipid storage impairs autophagic clearance of Alzheimer-associated proteins.
    Tamboli IY; Tien NT; Walter J
    Autophagy; 2011 Jun; 7(6):645-6. PubMed ID: 21460623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The A673T mutation in the amyloid precursor protein reduces the production of β-amyloid protein from its β-carboxyl terminal fragment in cells.
    Kokawa A; Ishihara S; Fujiwara H; Nobuhara M; Iwata M; Ihara Y; Funamoto S
    Acta Neuropathol Commun; 2015 Nov; 3():66. PubMed ID: 26531305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The η-secretase-derived APP fragment ηCTF is localized in Golgi, endosomes and extracellular vesicles and contributes to Aβ production.
    Afram E; Lauritzen I; Bourgeois A; El Manaa W; Duplan E; Chami M; Valverde A; Charlotte B; Pardossi-Piquard R; Checler F
    Cell Mol Life Sci; 2023 Mar; 80(4):97. PubMed ID: 36930302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homodimerization Protects the Amyloid Precursor Protein C99 Fragment from Cleavage by γ-Secretase.
    Winkler E; Julius A; Steiner H; Langosch D
    Biochemistry; 2015 Oct; 54(40):6149-52. PubMed ID: 26403946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.